Kenneth Cartwright
President chez Cmrc Consulting LLC
Profil
Kenneth Cartwright is currently the Director & SVP-Regulatory Affairs at Tetragenex Pharmaceuticals, Inc. He is also the President of Cmrc Consulting LLC.
Previously, he worked as the Director-Clinical Research at Wyeth Holdings LLC from 1982 to 1989.
He also served as the Medical Director & Director-Marketing at Ciba-Geigy Denmark.
In addition, he was the SVP-Development & Regulatory Affairs at Synvista Therapeutics, Inc. from 1994 to 1999.
Dr. Cartwright obtained his undergraduate degree from The University of Liverpool in 1959 and his doctorate from The Royal College of Physicians in 1971.
Postes actifs de Kenneth Cartwright
| Sociétés | Poste | Début |
|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Directeur/Membre du Conseil | 05/02/2010 |
| Cmrc Consulting LLC | President | 05/02/2010 |
Anciens postes connus de Kenneth Cartwright
| Sociétés | Poste | Fin |
|---|---|---|
| SYNVISTA THERAPEUTICS, INC. | Conseiller Juridique Général | 02/01/1999 |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Directeur Technique/Scientifique/R&D | 02/01/1989 |
| Ciba-Geigy Denmark | Directeur Technique/Scientifique/R&D | - |
Formation de Kenneth Cartwright
| The University of Liverpool | Undergraduate Degree |
| The Royal College of Physicians | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNVISTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| Cmrc Consulting LLC | |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
| Ciba-Geigy Denmark |
